A philips representative reported that during a cardiac lead management procedure to extract 2 infected implantable cardioverter defibrillator (icd) leads, a spectranetics lead locking device (lld) ex was utilized to remove the leads.The first lead was successfully removed.While applying traction to remove the second lead, the lld ex broke.There was enough of the lld left over to continue traction with the spectranetics glidelight laser sheath.The second lead was successfully removed.While there was an injury to the patient during this case, which has been reported separately from this product problem under mdr 1721279-2019-00004, there was no harm to the patient caused or contributed to by the malfunction of the spectranetics lead locking device.Therefore, the two events are being reported separately.
|